应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LH 徕博科
休市中 05-03 16:00:00 EDT
201.32
+1.07
+0.53%
盘后
201.32
+0.00
0.00%
17:30 EDT
最高
202.92
最低
199.68
成交量
55.57万
今开
201.12
昨收
200.25
日振幅
1.62%
总市值
169.70亿
流通市值
168.82亿
总股本
8,429万
成交额
1.12亿
换手率
0.66%
流通股本
8,386万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
徕博科跌0.71% 股价跌破200美元大关
自选股智能写手 · 05-01
徕博科跌0.71% 股价跌破200美元大关
美国 FDA 发布实验室开发测试的最终规则
Reuters · 04-29
美国 FDA 发布实验室开发测试的最终规则
徕博科2024财年第一财季实现净利润2.28亿美元,同比增加7.04%
自选股智能写手 · 04-29
徕博科2024财年第一财季实现净利润2.28亿美元,同比增加7.04%
Truist Securities:维持Laboratory Corp(LH.US)评级,由买入调整至买入评级, 目标价由270.00美元调整至255.00美元。
智通财经 · 04-26
Truist Securities:维持Laboratory Corp(LH.US)评级,由买入调整至买入评级, 目标价由270.00美元调整至255.00美元。
徕博科涨0.84% 股价突破200美元大关
自选股智能写手 · 04-26
徕博科涨0.84% 股价突破200美元大关
BUZZ-生命科学部门预期疲软,Labcorp业绩下滑
Reuters · 04-26
BUZZ-生命科学部门预期疲软,Labcorp业绩下滑
美国实验室控股公司公布截至三月份的季度业绩 - 收益摘要
Reuters · 04-25
美国实验室控股公司公布截至三月份的季度业绩 - 收益摘要
徕博科跌3.94% 股价跌破200美元大关
自选股智能写手 · 04-25
徕博科跌3.94% 股价跌破200美元大关
今日优惠-合并与收购
Reuters · 04-25
今日优惠-合并与收购
临床实验室运营商 Labcorp 将以 2.39 亿美元收购破产的基因测试制造商 Invitae
Reuters · 04-25
临床实验室运营商 Labcorp 将以 2.39 亿美元收购破产的基因测试制造商 Invitae
预计美国实验室控股公司 每股收益3.48美元 - 财报前瞻
Reuters · 04-23
预计美国实验室控股公司 每股收益3.48美元 - 财报前瞻
徕博科涨0.04% 股价突破200美元大关
自选股智能写手 · 04-18
徕博科涨0.04% 股价突破200美元大关
徕博科跌1.00% 股价跌破200美元大关
自选股智能写手 · 04-18
徕博科跌1.00% 股价跌破200美元大关
BUZZ-Labcorp 将收购 OPKO Health 旗下部分资产;OPKO 股价上涨
Reuters · 03-28
BUZZ-Labcorp 将收购 OPKO Health 旗下部分资产;OPKO 股价上涨
徕博科2023财年实现净利润3.79亿美元,同比减少70.37%
自选股智能写手 · 02-19
徕博科2023财年实现净利润3.79亿美元,同比减少70.37%
检测需求强劲,Labcorp 预测 2024 年利润高于预期
Reuters · 02-15
检测需求强劲,Labcorp 预测 2024 年利润高于预期
预计美国实验室控股公司 每股收益3.26美元 - 财报前瞻
Reuters · 02-13
预计美国实验室控股公司 每股收益3.26美元 - 财报前瞻
暂无数据
公司概况
公司名称:
徕博科
所属市场:
NYSE
上市日期:
--
主营业务:
Laboratory Corporation Of America Holdings是特拉华州的一家公司,成立于1971年。公司是一家领先的全球生命科学公司,已在指导患者护理方面深入整合。公司通过其LabCorp诊断(LCD)和Covance药物开发(CDD)部门提供全面的临床实验室和端到端药物开发服务。LabCorp定位于研究和护理交付的融合,以实现更精确和个性化的医疗保健,将世界一流的诊断和药物开发能力结合在一起。
发行价格:
--
{"stockData":{"symbol":"LH","market":"US","secType":"STK","nameCN":"徕博科","latestPrice":201.32,"timestamp":1714766400000,"preClose":200.25,"halted":0,"volume":555654,"hourTrading":{"tag":"盘后","latestPrice":201.32,"preClose":201.32,"latestTime":"17:30 EDT","volume":14011,"amount":2820702.8523,"timestamp":1714771808547},"delay":0,"floatShares":83857138,"shares":84293628,"eps":5.001918,"marketStatus":"休市中","marketStatusCode":7,"change":1.07,"latestTime":"05-03 16:00:00 EDT","open":201.12,"high":202.92,"low":199.68,"amount":111748642.79568,"amplitude":0.01618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.001918,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":672379200000,"adjPreClose":200.25,"adrRate":0,"dividendRate":0.014306,"postHourTrading":{"tag":"盘后","latestPrice":201.32,"preClose":201.32,"latestTime":"17:30 EDT","volume":14011,"amount":2820702.8523,"timestamp":1714771808547},"volumeRatio":0.6036940399180057},"requestUrl":"/m/hq/s/LH/tweets","defaultTab":"tweets","newsList":[{"id":"2432910570","title":"徕博科跌0.71% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2432910570","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432910570?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:42","pubTimestamp":1714570961,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时42分,徕博科股票出现波动,股价快速下挫0.71%。截至发稿,该股报199.95美元/股,成交量2.0198万股,换手率0.02%,振幅0.63%。机构评级方面,在所有20家参与评级的机构中,70%的券商给予买入建议,30%的券商给予持有建议,无券商给予卖出建议。徕博科股票所在的生命科学行业中,整体涨幅为0.52%。徕博科公司简介:Laboratory Corp of America Holdings是美国最大的两家独立临床实验室之一,约占独立实验室市场的 20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012142417a57db81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012142417a57db81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431520869","title":"美国 FDA 发布实验室开发测试的最终规则","url":"https://stock-news.laohu8.com/highlight/detail?id=2431520869","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431520869?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:55","pubTimestamp":1714398935,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透4月29日 - 美国食品和药物管理局(FDA) 周一公布了最终规则,以确保实验室开发的检测项目的安全性和有效性(LDTs),这些检测项目是在临床实验室内设计、制造和使用的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431062168","title":"徕博科2024财年第一财季实现净利润2.28亿美元,同比增加7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431062168","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431062168?lang=zh_cn&edition=full","pubTime":"2024-04-29 00:26","pubTimestamp":1714321612,"startTime":"0","endTime":"0","summary":"3月31日,徕博科公布财报,公告显示公司2024财年第一财季净利润为2.28亿美元,同比增加7.04%;其中营业收入为31.77亿美元,同比减少15.91%,每股基本收益为2.71美元。从资产负债表来看,徕博科总负债85.56亿美元,其中短期债务22.19亿美元,资产负债比为1.94,流动比率为0.88。机构评级:截至2024年3月31日,当前有15家机构对徕博科目标价做出预测,其中目标均价为241.41美元,其中最低目标价为210.00美元,最高目标价为262.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042900265887bb7805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042900265887bb7805&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430200670","title":"Truist Securities:维持Laboratory Corp(LH.US)评级,由买入调整至买入评级, 目标价由270.00美元调整至255.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430200670","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430200670?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:55","pubTimestamp":1714146924,"startTime":"0","endTime":"0","summary":"Truist Securities:维持Laboratory Corp(LH.US)评级,由买入调整至买入评级, 目标价由270.00美元调整至255.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042623552887b4542a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042623552887b4542a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430208058","title":"徕博科涨0.84% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2430208058","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430208058?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:03","pubTimestamp":1714140205,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日22时03分,徕博科股票出现波动,股价快速上涨0.84%。截至发稿,该股报200.02美元/股,成交量4.7356万股,换手率0.06%,振幅1.07%。徕博科股票所在的生命科学行业中,整体涨幅为0.53%。消息层面,截至22时03分,《Earnings Call Summary | Laboratory Corp of America Q1 2024 Earnings Conference》资讯为影响徕博科的重要信息。该信息摘要如下:收购Invitae资产预计将带来2.75亿至3亿美元的年收入,收购价为2.39亿美元。收购Invitae的资产预计将促进Labcorp在肿瘤学和罕见疾病等领域的专业测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622032687e84363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622032687e84363&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231994","title":"BUZZ-生命科学部门预期疲软,Labcorp业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231994","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430231994?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:48","pubTimestamp":1714063737,"startTime":"0","endTime":"0","summary":" 4月25日 - ** 实验室服务提供商Labcorp的 股价下跌5.7%,跌至196.11美元的六个月低点。** 公司第一季度每股收益为3.68美元,高于预期的3.48美元 - LSEG** Labcorp 对其生命科学部门的预测较弱,即其药物早期开发服务面临的取消率居高不下,这可能会对其股价构成压力 - Baird 券商** 股价走势与SPDR S&P Biotech ETF 走势一致,后者下跌2.8%--券商** Labcorp将其合同研究部门的增长预期下调至3.7%至5.7%,而之前的预期为增长5.5%至7.5%。** 年初至今,Labcorp 的股价下跌了 8.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430281352","title":"美国实验室控股公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281352","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430281352?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:06","pubTimestamp":1714054002,"startTime":"0","endTime":"0","summary":" * Laboratory Corporation of America Holdings 公布的截至3月底的季度调整后每股收益为3.68美元,低于去年同期的每股收益3.82美元。16 位分析师对该季度的平均预期为每股收益 3.48 美元。华尔街预期为每股收益 3.30 美元至 3.59 美元。* 美国实验室控股公司公布的本季度每股收益为 2.69 美元。* 公司季度净收入为 2.28 亿美元。* 美国实验室控股公司本季度股价下跌了 4.8%,今年迄今为止下跌了 8.5%。华尔街对美国实验室控股公司 12 个月目标价的中位数为 245.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430628921","title":"徕博科跌3.94% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2430628921","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430628921?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:04","pubTimestamp":1714053857,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时04分,徕博科股票出现异动,股价急速下跌3.94%。截至发稿,该股报199.75美元/股,成交量19.6385万股,换手率0.23%,振幅2.38%。最近的财报数据显示,该股实现营业收入121.62亿美元,净利润3.79亿美元,每股收益4.80美元,毛利31.45亿美元,市盈率41.93倍。徕博科股票所在的生命科学行业中,整体跌幅为1.57%。徕博科公司简介:Laboratory Corp of America Holdings是美国最大的两家独立临床实验室之一,约占独立实验室市场的 20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425220418792378e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425220418792378e5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430472145","title":"今日优惠-合并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2430472145","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430472145?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:01","pubTimestamp":1714039279,"startTime":"0","endTime":"0","summary":"** 必和必拓集团 表示,它已向英美资源集团 提出了388亿美元的收购要约,提出的交易将创造世界上最大的铜矿企业,并使其较小竞争对手的股价大幅走高。** 海斯公司 周三表示,其董事会已将 4 月 12 日定为确定有权就与雪佛龙公司 的拟议合并进行投票的股东的记录日期。** 私募股权投资公司 Blackstone 周三表示,已同意收购 Tropical Smoothie Cafe,据消息人士称,该连锁餐厅的估值为 20 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430417446","title":"临床实验室运营商 Labcorp 将以 2.39 亿美元收购破产的基因测试制造商 Invitae","url":"https://stock-news.laohu8.com/highlight/detail?id=2430417446","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430417446?lang=zh_cn&edition=full","pubTime":"2024-04-25 10:23","pubTimestamp":1714011800,"startTime":"0","endTime":"0","summary":" 路透社4月25日 - 实验室服务提供商Labcorp 周三表示,它将收购软银支持的 Invitae Corp 通过自愿破产保护程序拍卖的资产,而在此之前几个月,这家基因测试制造商申请了破产。Labcorp和Invitae分别在声明中表示,Labcorp将以2.39亿美元的现金对价和其他非现金对价收购这家破产公司的全部资产。今年 2 月,Invitae 向美国一家破产法院自愿申请破产保护,并表示 ,该公司打算进行出售。根据破产申请,Invitae 的资产估计在 5 亿至 10 亿美元之间,负债在 10 亿至 100 亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429156741","title":"预计美国实验室控股公司 每股收益3.48美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429156741","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429156741?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:30","pubTimestamp":1713882621,"startTime":"0","endTime":"0","summary":" * 美国实验室控股公司 将于4月25日公布截至2024年3月31日的业绩报告,预计该公司的季度收入将出现下降。 * LSEG 的分析师平均预期美国实验室控股公司每股收益为 3.48 美元。* 华尔街对美国实验室控股公司的 12 个月目标价中值为 245.00 美元,高于其上次收盘价 203.07 美元。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428592441","title":"徕博科涨0.04% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2428592441","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428592441?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:40","pubTimestamp":1713447617,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时40分,徕博科股票出现异动,股价大幅拉升0.04%。截至发稿,该股报200.05美元/股,成交量7871股,换手率0.01%,振幅0.30%。机构评级方面,在所有20家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。徕博科股票所在的生命科学行业中,整体跌幅为1.74%。徕博科公司简介:Laboratory Corp of America Holdings是美国最大的两家独立临床实验室之一,约占独立实验室市场的 20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821401787e81bcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821401787e81bcc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428753293","title":"徕博科跌1.00% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2428753293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428753293?lang=zh_cn&edition=full","pubTime":"2024-04-18 04:00","pubTimestamp":1713384008,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日04时00分,徕博科股票出现波动,股价快速跳水1.00%。截至发稿,该股报199.92美元/股,成交量48.0768万股,换手率0.57%,振幅1.24%。机构评级方面,在所有20家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。徕博科股票所在的生命科学行业中,整体跌幅为1.32%。徕博科公司简介:Laboratory Corp of America Holdings是美国最大的两家独立临床实验室之一,约占独立实验室市场的 20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180400087a5382ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180400087a5382ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422196549","title":"BUZZ-Labcorp 将收购 OPKO Health 旗下部分资产;OPKO 股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2422196549","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422196549?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:06","pubTimestamp":1711631188,"startTime":"0","endTime":"0","summary":" 3月28日 - ** 医疗保健公司OPKO Health的 股价盘前上涨2.8%至1.10美元 ** 临床实验室运营商Labcorp 将以2.375亿美元的价格收购OPKO Health旗下BioReference Health公司的部分资产 ** LH将收购的资产目前年收入约为1亿美元** 通过此次交易,LH 将收购 BioReference 在全美的实验室检测业务,重点是临床诊断和妇女健康。** 两家公司表示,BioReference 将继续在全国范围内提供肿瘤学和泌尿学诊断服务,并保持在纽约和新泽西州的全面运营 ** 预计交易将于 2024 年下半年完成** 截至上次收盘,OPK 年累计下跌 29.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412997172","title":"徕博科2023财年实现净利润3.79亿美元,同比减少70.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412997172","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412997172?lang=zh_cn&edition=full","pubTime":"2024-02-19 00:21","pubTimestamp":1708273266,"startTime":"0","endTime":"0","summary":"12月31日,徕博科公布财报,公告显示公司2023财年净利润为3.79亿美元,同比减少70.37%;其中营业收入为121.62亿美元,同比减少18.25%,每股基本收益为4.80美元。从资产负债表来看,徕博科总负债88.35亿美元,其中短期债务11.72亿美元,资产负债比为1.90,流动比率为1.17。机构评级:截至2023年12月31日,当前有14家机构对徕博科目标价做出预测,其中目标均价为245.71美元,其中最低目标价为220.00美元,最高目标价为270.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021900211681995112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021900211681995112&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411517354","title":"检测需求强劲,Labcorp 预测 2024 年利润高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2411517354","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411517354?lang=zh_cn&edition=full","pubTime":"2024-02-15 20:35","pubTimestamp":1708000533,"startTime":"0","endTime":"0","summary":"医疗保健利用率的提高使美国实验室检测公司受益匪浅,其中包括Labcorp的竞争对手Quest Diagnostics ,该公司预测 ,2024 年的销售额将强劲增长,并将赌注押在对诊断试剂盒的需求上。Labcorp 是美国第二大独立实验室检测服务提供商,也是美国合同研究服务的主要提供商之一。Labcorp 曾预测,诊断业务在未来三年将增长 2.5% 至 4.5%。Labcorp预计,2024年企业总收入将增长4.7%至6.5%。调整后的每股收益为 3.30 美元,高于预期的 3.26 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411352203","title":"预计美国实验室控股公司 每股收益3.26美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2411352203","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411352203?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:06","pubTimestamp":1707833175,"startTime":"0","endTime":"0","summary":" * 美国实验室控股公司 将于2月15日公布截至2023年12月31日的业绩报告,预计该公司的季度收入将出现下降。 * LSEG 的分析师平均预期美国实验室控股公司每股收益为 3.26 美元。* 华尔街对美国实验室控股公司的 12 个月目标价中值为 242.00 美元,高于其上次收盘价 227.45 美元。2月13日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.labcorp.com","stockEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":-0.0515},{"period":"3month","weight":-0.0913},{"period":"6month","weight":-0.0423},{"period":"1year","weight":-0.0921},{"period":"ytd","weight":-0.1143}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Laboratory Corporation Of America Holdings是特拉华州的一家公司,成立于1971年。公司是一家领先的全球生命科学公司,已在指导患者护理方面深入整合。公司通过其LabCorp诊断(LCD)和Covance药物开发(CDD)部门提供全面的临床实验室和端到端药物开发服务。LabCorp定位于研究和护理交付的融合,以实现更精确和个性化的医疗保健,将世界一流的诊断和药物开发能力结合在一起。","yearOnYearQuotes":[{"month":1,"riseRate":0.62069,"avgChangeRate":0.022916},{"month":2,"riseRate":0.586207,"avgChangeRate":0.024284},{"month":3,"riseRate":0.655172,"avgChangeRate":-0.002971},{"month":4,"riseRate":0.689655,"avgChangeRate":0.055853},{"month":5,"riseRate":0.482759,"avgChangeRate":0.008478},{"month":6,"riseRate":0.551724,"avgChangeRate":0.023824},{"month":7,"riseRate":0.482759,"avgChangeRate":0.007916},{"month":8,"riseRate":0.413793,"avgChangeRate":-0.037022},{"month":9,"riseRate":0.448276,"avgChangeRate":-0.004118},{"month":10,"riseRate":0.551724,"avgChangeRate":-0.000326},{"month":11,"riseRate":0.655172,"avgChangeRate":0.005266},{"month":12,"riseRate":0.758621,"avgChangeRate":0.01945}],"exchange":"NYSE","name":"徕博科","nameEN":"Laboratory Corp of America"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"徕博科(LH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供徕博科(LH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"徕博科,LH,徕博科股票,徕博科股票老虎,徕博科股票老虎国际,徕博科行情,徕博科股票行情,徕博科股价,徕博科股市,徕博科股票价格,徕博科股票交易,徕博科股票购买,徕博科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"徕博科(LH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供徕博科(LH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}